nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Sulfasalazine—ankylosing spondylitis	0.156	0.181	CbGbCtD
Zafirlukast—PTGS1—Sulfasalazine—ankylosing spondylitis	0.144	0.167	CbGbCtD
Zafirlukast—ABCG2—Dexamethasone—ankylosing spondylitis	0.078	0.0902	CbGbCtD
Zafirlukast—ABCG2—Methotrexate—ankylosing spondylitis	0.0627	0.0725	CbGbCtD
Zafirlukast—CYP2C19—Prednisone—ankylosing spondylitis	0.0558	0.0646	CbGbCtD
Zafirlukast—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0556	0.0643	CbGbCtD
Zafirlukast—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0445	0.0515	CbGbCtD
Zafirlukast—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0415	0.0481	CbGbCtD
Zafirlukast—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0348	0.0403	CbGbCtD
Zafirlukast—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0337	0.0391	CbGbCtD
Zafirlukast—CYP2C9—Dexamethasone—ankylosing spondylitis	0.029	0.0335	CbGbCtD
Zafirlukast—CYP3A4—Betamethasone—ankylosing spondylitis	0.029	0.0335	CbGbCtD
Zafirlukast—CYP3A4—Prednisolone—ankylosing spondylitis	0.0286	0.0331	CbGbCtD
Zafirlukast—CYP3A4—Prednisone—ankylosing spondylitis	0.027	0.0312	CbGbCtD
Zafirlukast—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0265	0.0307	CbGbCtD
Zafirlukast—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0168	0.0195	CbGbCtD
Zafirlukast—Increased tendency to bruise—Methylprednisolone—ankylosing spondylitis	0.00848	0.0623	CcSEcCtD
Zafirlukast—Blister—Prednisolone—ankylosing spondylitis	0.00198	0.0146	CcSEcCtD
Zafirlukast—Raised liver function tests—Methotrexate—ankylosing spondylitis	0.00188	0.0138	CcSEcCtD
Zafirlukast—Throat sore—Triamcinolone—ankylosing spondylitis	0.00182	0.0134	CcSEcCtD
Zafirlukast—Blister—Triamcinolone—ankylosing spondylitis	0.00182	0.0134	CcSEcCtD
Zafirlukast—Oropharyngeal discomfort—Triamcinolone—ankylosing spondylitis	0.00181	0.0133	CcSEcCtD
Zafirlukast—Leukocytoclastic vasculitis—Methotrexate—ankylosing spondylitis	0.00177	0.013	CcSEcCtD
Zafirlukast—Blister—Dexamethasone—ankylosing spondylitis	0.00165	0.0122	CcSEcCtD
Zafirlukast—Blister—Betamethasone—ankylosing spondylitis	0.00165	0.0122	CcSEcCtD
Zafirlukast—Vasculitis—Prednisolone—ankylosing spondylitis	0.00146	0.0108	CcSEcCtD
Zafirlukast—Oropharyngeal pain—Triamcinolone—ankylosing spondylitis	0.00145	0.0106	CcSEcCtD
Zafirlukast—Contusion—Betamethasone—ankylosing spondylitis	0.00137	0.01	CcSEcCtD
Zafirlukast—Contusion—Dexamethasone—ankylosing spondylitis	0.00137	0.01	CcSEcCtD
Zafirlukast—Vasculitis—Triamcinolone—ankylosing spondylitis	0.00135	0.00989	CcSEcCtD
Zafirlukast—Vasculitis—Methylprednisolone—ankylosing spondylitis	0.00134	0.00987	CcSEcCtD
Zafirlukast—Neuropathy—Prednisolone—ankylosing spondylitis	0.00134	0.00986	CcSEcCtD
Zafirlukast—Haematemesis—Methotrexate—ankylosing spondylitis	0.00125	0.00918	CcSEcCtD
Zafirlukast—Neuropathy—Triamcinolone—ankylosing spondylitis	0.00123	0.00907	CcSEcCtD
Zafirlukast—Neuropathy—Methylprednisolone—ankylosing spondylitis	0.00123	0.00905	CcSEcCtD
Zafirlukast—Vasculitis—Betamethasone—ankylosing spondylitis	0.00122	0.00898	CcSEcCtD
Zafirlukast—Vasculitis—Dexamethasone—ankylosing spondylitis	0.00122	0.00898	CcSEcCtD
Zafirlukast—Contusion—Prednisone—ankylosing spondylitis	0.00119	0.00875	CcSEcCtD
Zafirlukast—Injury—Prednisolone—ankylosing spondylitis	0.00113	0.00829	CcSEcCtD
Zafirlukast—Hepatotoxicity—Methotrexate—ankylosing spondylitis	0.00112	0.00826	CcSEcCtD
Zafirlukast—Neuropathy—Betamethasone—ankylosing spondylitis	0.00112	0.00823	CcSEcCtD
Zafirlukast—Neuropathy—Dexamethasone—ankylosing spondylitis	0.00112	0.00823	CcSEcCtD
Zafirlukast—Dermatitis bullous—Prednisolone—ankylosing spondylitis	0.00109	0.00798	CcSEcCtD
Zafirlukast—Vasculitis—Prednisone—ankylosing spondylitis	0.00106	0.00782	CcSEcCtD
Zafirlukast—Injury—Triamcinolone—ankylosing spondylitis	0.00104	0.00763	CcSEcCtD
Zafirlukast—Injury—Methylprednisolone—ankylosing spondylitis	0.00104	0.00761	CcSEcCtD
Zafirlukast—Dermatitis bullous—Triamcinolone—ankylosing spondylitis	0.000998	0.00734	CcSEcCtD
Zafirlukast—Neuropathy—Prednisone—ankylosing spondylitis	0.000975	0.00716	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Methotrexate—ankylosing spondylitis	0.000955	0.00701	CcSEcCtD
Zafirlukast—Injury—Dexamethasone—ankylosing spondylitis	0.000942	0.00692	CcSEcCtD
Zafirlukast—Injury—Betamethasone—ankylosing spondylitis	0.000942	0.00692	CcSEcCtD
Zafirlukast—Dermatitis bullous—Dexamethasone—ankylosing spondylitis	0.000906	0.00666	CcSEcCtD
Zafirlukast—Dermatitis bullous—Betamethasone—ankylosing spondylitis	0.000906	0.00666	CcSEcCtD
Zafirlukast—Vasculitis—Methotrexate—ankylosing spondylitis	0.000889	0.00653	CcSEcCtD
Zafirlukast—Injury—Prednisone—ankylosing spondylitis	0.00082	0.00603	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.000784	0.00576	CcSEcCtD
Zafirlukast—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000721	0.0053	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.000721	0.0053	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.000719	0.00528	CcSEcCtD
Zafirlukast—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000718	0.00527	CcSEcCtD
Zafirlukast—Hepatic failure—Methotrexate—ankylosing spondylitis	0.000701	0.00515	CcSEcCtD
Zafirlukast—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000663	0.00487	CcSEcCtD
Zafirlukast—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000662	0.00486	CcSEcCtD
Zafirlukast—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00066	0.00485	CcSEcCtD
Zafirlukast—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000659	0.00484	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000654	0.0048	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000654	0.0048	CcSEcCtD
Zafirlukast—Neutropenia—Prednisone—ankylosing spondylitis	0.000609	0.00448	CcSEcCtD
Zafirlukast—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000602	0.00442	CcSEcCtD
Zafirlukast—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000602	0.00442	CcSEcCtD
Zafirlukast—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000599	0.0044	CcSEcCtD
Zafirlukast—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000599	0.0044	CcSEcCtD
Zafirlukast—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000582	0.00427	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00058	0.00426	CcSEcCtD
Zafirlukast—Angioedema—Prednisolone—ankylosing spondylitis	0.000571	0.00419	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00057	0.00418	CcSEcCtD
Zafirlukast—Malaise—Prednisolone—ankylosing spondylitis	0.000564	0.00414	CcSEcCtD
Zafirlukast—Back pain—Triamcinolone—ankylosing spondylitis	0.000556	0.00408	CcSEcCtD
Zafirlukast—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000539	0.00396	CcSEcCtD
Zafirlukast—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000533	0.00392	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000532	0.00391	CcSEcCtD
Zafirlukast—Discomfort—Prednisolone—ankylosing spondylitis	0.000526	0.00386	CcSEcCtD
Zafirlukast—Angioedema—Triamcinolone—ankylosing spondylitis	0.000525	0.00386	CcSEcCtD
Zafirlukast—Haemoglobin—Prednisone—ankylosing spondylitis	0.000524	0.00385	CcSEcCtD
Zafirlukast—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000524	0.00385	CcSEcCtD
Zafirlukast—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000522	0.00384	CcSEcCtD
Zafirlukast—Haemorrhage—Prednisone—ankylosing spondylitis	0.000522	0.00383	CcSEcCtD
Zafirlukast—Malaise—Triamcinolone—ankylosing spondylitis	0.000518	0.00381	CcSEcCtD
Zafirlukast—Malaise—Methylprednisolone—ankylosing spondylitis	0.000517	0.0038	CcSEcCtD
Zafirlukast—Oedema—Prednisolone—ankylosing spondylitis	0.00051	0.00375	CcSEcCtD
Zafirlukast—Neutropenia—Methotrexate—ankylosing spondylitis	0.000509	0.00374	CcSEcCtD
Zafirlukast—Myalgia—Triamcinolone—ankylosing spondylitis	0.000489	0.00359	CcSEcCtD
Zafirlukast—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000488	0.00359	CcSEcCtD
Zafirlukast—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000488	0.00359	CcSEcCtD
Zafirlukast—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000484	0.00355	CcSEcCtD
Zafirlukast—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000484	0.00355	CcSEcCtD
Zafirlukast—Discomfort—Triamcinolone—ankylosing spondylitis	0.000483	0.00355	CcSEcCtD
Zafirlukast—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000482	0.00354	CcSEcCtD
Zafirlukast—Angioedema—Dexamethasone—ankylosing spondylitis	0.000476	0.0035	CcSEcCtD
Zafirlukast—Angioedema—Betamethasone—ankylosing spondylitis	0.000476	0.0035	CcSEcCtD
Zafirlukast—Malaise—Betamethasone—ankylosing spondylitis	0.00047	0.00345	CcSEcCtD
Zafirlukast—Malaise—Dexamethasone—ankylosing spondylitis	0.00047	0.00345	CcSEcCtD
Zafirlukast—Oedema—Triamcinolone—ankylosing spondylitis	0.000469	0.00345	CcSEcCtD
Zafirlukast—Infection—Triamcinolone—ankylosing spondylitis	0.000466	0.00342	CcSEcCtD
Zafirlukast—Infection—Methylprednisolone—ankylosing spondylitis	0.000465	0.00342	CcSEcCtD
Zafirlukast—Insomnia—Prednisolone—ankylosing spondylitis	0.000461	0.00339	CcSEcCtD
Zafirlukast—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000453	0.00333	CcSEcCtD
Zafirlukast—Myalgia—Dexamethasone—ankylosing spondylitis	0.000444	0.00326	CcSEcCtD
Zafirlukast—Myalgia—Betamethasone—ankylosing spondylitis	0.000444	0.00326	CcSEcCtD
Zafirlukast—Discomfort—Betamethasone—ankylosing spondylitis	0.000439	0.00322	CcSEcCtD
Zafirlukast—Discomfort—Dexamethasone—ankylosing spondylitis	0.000439	0.00322	CcSEcCtD
Zafirlukast—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000438	0.00322	CcSEcCtD
Zafirlukast—Pain—Prednisolone—ankylosing spondylitis	0.000436	0.0032	CcSEcCtD
Zafirlukast—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000436	0.0032	CcSEcCtD
Zafirlukast—Hepatitis—Methotrexate—ankylosing spondylitis	0.000436	0.0032	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000427	0.00314	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000426	0.00313	CcSEcCtD
Zafirlukast—Oedema—Betamethasone—ankylosing spondylitis	0.000426	0.00313	CcSEcCtD
Zafirlukast—Oedema—Dexamethasone—ankylosing spondylitis	0.000426	0.00313	CcSEcCtD
Zafirlukast—Insomnia—Triamcinolone—ankylosing spondylitis	0.000424	0.00312	CcSEcCtD
Zafirlukast—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000423	0.00311	CcSEcCtD
Zafirlukast—Infection—Betamethasone—ankylosing spondylitis	0.000423	0.00311	CcSEcCtD
Zafirlukast—Infection—Dexamethasone—ankylosing spondylitis	0.000423	0.00311	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000421	0.0031	CcSEcCtD
Zafirlukast—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00042	0.00309	CcSEcCtD
Zafirlukast—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000417	0.00306	CcSEcCtD
Zafirlukast—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000417	0.00306	CcSEcCtD
Zafirlukast—Angioedema—Prednisone—ankylosing spondylitis	0.000415	0.00305	CcSEcCtD
Zafirlukast—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000413	0.00303	CcSEcCtD
Zafirlukast—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000412	0.00303	CcSEcCtD
Zafirlukast—Malaise—Prednisone—ankylosing spondylitis	0.000409	0.00301	CcSEcCtD
Zafirlukast—Urticaria—Prednisolone—ankylosing spondylitis	0.000405	0.00298	CcSEcCtD
Zafirlukast—Fatigue—Triamcinolone—ankylosing spondylitis	0.000404	0.00297	CcSEcCtD
Zafirlukast—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000403	0.00296	CcSEcCtD
Zafirlukast—Pain—Triamcinolone—ankylosing spondylitis	0.000401	0.00295	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000388	0.00285	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000388	0.00285	CcSEcCtD
Zafirlukast—Arthralgia—Prednisone—ankylosing spondylitis	0.000387	0.00284	CcSEcCtD
Zafirlukast—Myalgia—Prednisone—ankylosing spondylitis	0.000387	0.00284	CcSEcCtD
Zafirlukast—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000386	0.00284	CcSEcCtD
Zafirlukast—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000386	0.00283	CcSEcCtD
Zafirlukast—Insomnia—Betamethasone—ankylosing spondylitis	0.000385	0.00283	CcSEcCtD
Zafirlukast—Insomnia—Dexamethasone—ankylosing spondylitis	0.000385	0.00283	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000383	0.00281	CcSEcCtD
Zafirlukast—Discomfort—Prednisone—ankylosing spondylitis	0.000382	0.00281	CcSEcCtD
Zafirlukast—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000376	0.00276	CcSEcCtD
Zafirlukast—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000375	0.00275	CcSEcCtD
Zafirlukast—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000375	0.00275	CcSEcCtD
Zafirlukast—Urticaria—Triamcinolone—ankylosing spondylitis	0.000373	0.00274	CcSEcCtD
Zafirlukast—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000372	0.00273	CcSEcCtD
Zafirlukast—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000371	0.00272	CcSEcCtD
Zafirlukast—Oedema—Prednisone—ankylosing spondylitis	0.000371	0.00272	CcSEcCtD
Zafirlukast—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00037	0.00272	CcSEcCtD
Zafirlukast—Infection—Prednisone—ankylosing spondylitis	0.000368	0.0027	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000367	0.0027	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000367	0.0027	CcSEcCtD
Zafirlukast—Back pain—Methotrexate—ankylosing spondylitis	0.000367	0.0027	CcSEcCtD
Zafirlukast—Fatigue—Dexamethasone—ankylosing spondylitis	0.000367	0.0027	CcSEcCtD
Zafirlukast—Fatigue—Betamethasone—ankylosing spondylitis	0.000367	0.0027	CcSEcCtD
Zafirlukast—Pain—Betamethasone—ankylosing spondylitis	0.000364	0.00267	CcSEcCtD
Zafirlukast—Pain—Dexamethasone—ankylosing spondylitis	0.000364	0.00267	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000352	0.00259	CcSEcCtD
Zafirlukast—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000351	0.00258	CcSEcCtD
Zafirlukast—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000351	0.00258	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000348	0.00256	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000348	0.00256	CcSEcCtD
Zafirlukast—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000346	0.00254	CcSEcCtD
Zafirlukast—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000345	0.00253	CcSEcCtD
Zafirlukast—Malaise—Methotrexate—ankylosing spondylitis	0.000342	0.00251	CcSEcCtD
Zafirlukast—Urticaria—Dexamethasone—ankylosing spondylitis	0.000338	0.00248	CcSEcCtD
Zafirlukast—Urticaria—Betamethasone—ankylosing spondylitis	0.000338	0.00248	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000338	0.00248	CcSEcCtD
Zafirlukast—Dizziness—Prednisolone—ankylosing spondylitis	0.000337	0.00248	CcSEcCtD
Zafirlukast—Asthenia—Triamcinolone—ankylosing spondylitis	0.000336	0.00247	CcSEcCtD
Zafirlukast—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000336	0.00247	CcSEcCtD
Zafirlukast—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000336	0.00247	CcSEcCtD
Zafirlukast—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000336	0.00247	CcSEcCtD
Zafirlukast—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000336	0.00247	CcSEcCtD
Zafirlukast—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000336	0.00247	CcSEcCtD
Zafirlukast—Insomnia—Prednisone—ankylosing spondylitis	0.000335	0.00246	CcSEcCtD
Zafirlukast—Pruritus—Triamcinolone—ankylosing spondylitis	0.000332	0.00244	CcSEcCtD
Zafirlukast—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000331	0.00243	CcSEcCtD
Zafirlukast—Dyspepsia—Prednisone—ankylosing spondylitis	0.000326	0.0024	CcSEcCtD
Zafirlukast—Arthralgia—Methotrexate—ankylosing spondylitis	0.000323	0.00237	CcSEcCtD
Zafirlukast—Myalgia—Methotrexate—ankylosing spondylitis	0.000323	0.00237	CcSEcCtD
Zafirlukast—Rash—Prednisolone—ankylosing spondylitis	0.000322	0.00236	CcSEcCtD
Zafirlukast—Dermatitis—Prednisolone—ankylosing spondylitis	0.000321	0.00236	CcSEcCtD
Zafirlukast—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00032	0.00235	CcSEcCtD
Zafirlukast—Fatigue—Prednisone—ankylosing spondylitis	0.00032	0.00235	CcSEcCtD
Zafirlukast—Headache—Prednisolone—ankylosing spondylitis	0.000319	0.00235	CcSEcCtD
Zafirlukast—Discomfort—Methotrexate—ankylosing spondylitis	0.000319	0.00235	CcSEcCtD
Zafirlukast—Dizziness—Triamcinolone—ankylosing spondylitis	0.00031	0.00228	CcSEcCtD
Zafirlukast—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000309	0.00227	CcSEcCtD
Zafirlukast—Infection—Methotrexate—ankylosing spondylitis	0.000308	0.00226	CcSEcCtD
Zafirlukast—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000305	0.00224	CcSEcCtD
Zafirlukast—Asthenia—Dexamethasone—ankylosing spondylitis	0.000305	0.00224	CcSEcCtD
Zafirlukast—Asthenia—Betamethasone—ankylosing spondylitis	0.000305	0.00224	CcSEcCtD
Zafirlukast—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000303	0.00223	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000303	0.00223	CcSEcCtD
Zafirlukast—Nausea—Prednisolone—ankylosing spondylitis	0.000303	0.00223	CcSEcCtD
Zafirlukast—Pruritus—Betamethasone—ankylosing spondylitis	0.000301	0.00221	CcSEcCtD
Zafirlukast—Pruritus—Dexamethasone—ankylosing spondylitis	0.000301	0.00221	CcSEcCtD
Zafirlukast—Vomiting—Triamcinolone—ankylosing spondylitis	0.000298	0.00219	CcSEcCtD
Zafirlukast—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000298	0.00219	CcSEcCtD
Zafirlukast—Rash—Triamcinolone—ankylosing spondylitis	0.000296	0.00217	CcSEcCtD
Zafirlukast—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000295	0.00217	CcSEcCtD
Zafirlukast—Rash—Methylprednisolone—ankylosing spondylitis	0.000295	0.00217	CcSEcCtD
Zafirlukast—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000295	0.00217	CcSEcCtD
Zafirlukast—Urticaria—Prednisone—ankylosing spondylitis	0.000294	0.00216	CcSEcCtD
Zafirlukast—Headache—Triamcinolone—ankylosing spondylitis	0.000294	0.00216	CcSEcCtD
Zafirlukast—Headache—Methylprednisolone—ankylosing spondylitis	0.000293	0.00215	CcSEcCtD
Zafirlukast—Abdominal pain—Prednisone—ankylosing spondylitis	0.000293	0.00215	CcSEcCtD
Zafirlukast—Body temperature increased—Prednisone—ankylosing spondylitis	0.000293	0.00215	CcSEcCtD
Zafirlukast—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000291	0.00214	CcSEcCtD
Zafirlukast—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000291	0.00214	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000282	0.00207	CcSEcCtD
Zafirlukast—Dizziness—Dexamethasone—ankylosing spondylitis	0.000281	0.00207	CcSEcCtD
Zafirlukast—Dizziness—Betamethasone—ankylosing spondylitis	0.000281	0.00207	CcSEcCtD
Zafirlukast—Insomnia—Methotrexate—ankylosing spondylitis	0.00028	0.00206	CcSEcCtD
Zafirlukast—Nausea—Triamcinolone—ankylosing spondylitis	0.000279	0.00205	CcSEcCtD
Zafirlukast—Nausea—Methylprednisolone—ankylosing spondylitis	0.000278	0.00204	CcSEcCtD
Zafirlukast—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000273	0.00201	CcSEcCtD
Zafirlukast—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000273	0.002	CcSEcCtD
Zafirlukast—Vomiting—Dexamethasone—ankylosing spondylitis	0.000271	0.00199	CcSEcCtD
Zafirlukast—Vomiting—Betamethasone—ankylosing spondylitis	0.000271	0.00199	CcSEcCtD
Zafirlukast—Rash—Betamethasone—ankylosing spondylitis	0.000268	0.00197	CcSEcCtD
Zafirlukast—Rash—Dexamethasone—ankylosing spondylitis	0.000268	0.00197	CcSEcCtD
Zafirlukast—Dermatitis—Betamethasone—ankylosing spondylitis	0.000268	0.00197	CcSEcCtD
Zafirlukast—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000268	0.00197	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000267	0.00196	CcSEcCtD
Zafirlukast—Fatigue—Methotrexate—ankylosing spondylitis	0.000267	0.00196	CcSEcCtD
Zafirlukast—Headache—Dexamethasone—ankylosing spondylitis	0.000267	0.00196	CcSEcCtD
Zafirlukast—Headache—Betamethasone—ankylosing spondylitis	0.000267	0.00196	CcSEcCtD
Zafirlukast—Asthenia—Prednisone—ankylosing spondylitis	0.000266	0.00195	CcSEcCtD
Zafirlukast—Pain—Methotrexate—ankylosing spondylitis	0.000265	0.00195	CcSEcCtD
Zafirlukast—Pruritus—Prednisone—ankylosing spondylitis	0.000262	0.00193	CcSEcCtD
Zafirlukast—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000255	0.00188	CcSEcCtD
Zafirlukast—Diarrhoea—Prednisone—ankylosing spondylitis	0.000254	0.00186	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000253	0.00186	CcSEcCtD
Zafirlukast—Nausea—Dexamethasone—ankylosing spondylitis	0.000253	0.00186	CcSEcCtD
Zafirlukast—Nausea—Betamethasone—ankylosing spondylitis	0.000253	0.00186	CcSEcCtD
Zafirlukast—Urticaria—Methotrexate—ankylosing spondylitis	0.000246	0.00181	CcSEcCtD
Zafirlukast—Dizziness—Prednisone—ankylosing spondylitis	0.000245	0.0018	CcSEcCtD
Zafirlukast—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000245	0.0018	CcSEcCtD
Zafirlukast—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000245	0.0018	CcSEcCtD
Zafirlukast—Vomiting—Prednisone—ankylosing spondylitis	0.000236	0.00173	CcSEcCtD
Zafirlukast—Rash—Prednisone—ankylosing spondylitis	0.000234	0.00172	CcSEcCtD
Zafirlukast—Dermatitis—Prednisone—ankylosing spondylitis	0.000233	0.00172	CcSEcCtD
Zafirlukast—Headache—Prednisone—ankylosing spondylitis	0.000232	0.00171	CcSEcCtD
Zafirlukast—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000228	0.00168	CcSEcCtD
Zafirlukast—Asthenia—Methotrexate—ankylosing spondylitis	0.000222	0.00163	CcSEcCtD
Zafirlukast—Nausea—Prednisone—ankylosing spondylitis	0.00022	0.00162	CcSEcCtD
Zafirlukast—Pruritus—Methotrexate—ankylosing spondylitis	0.000219	0.00161	CcSEcCtD
Zafirlukast—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000212	0.00156	CcSEcCtD
Zafirlukast—Dizziness—Methotrexate—ankylosing spondylitis	0.000205	0.0015	CcSEcCtD
Zafirlukast—Vomiting—Methotrexate—ankylosing spondylitis	0.000197	0.00145	CcSEcCtD
Zafirlukast—Rash—Methotrexate—ankylosing spondylitis	0.000195	0.00143	CcSEcCtD
Zafirlukast—Dermatitis—Methotrexate—ankylosing spondylitis	0.000195	0.00143	CcSEcCtD
Zafirlukast—Headache—Methotrexate—ankylosing spondylitis	0.000194	0.00143	CcSEcCtD
Zafirlukast—Nausea—Methotrexate—ankylosing spondylitis	0.000184	0.00135	CcSEcCtD
